References
- Pui C H., Crist W M., Look A T. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphocytic leukemia. Blood 1990; 76: 1449–1463
- Mastrangelo R, Malandrino R, Riccardi R, Longo P, Ranelletti F D., Iacobelli S. Clinical implications of glucocorticoid receptor studies in childhood acute lymphoblastic leukemia. Blood 1980; 56: 1036–1040
- Kato G J., Quadus F F., Sinister J J., Boyett J, Pullen J D., Borowitz M J., Whitehead U M., Crist W M., Leventhal B G. High glucocorticoid receptor content of leukemic blasts is a favorable prognostic factor in childhood acute lymphoblastic leukemia. Blood 1993; 82(8)2304–2309
- Riehm H, Gadner G, Henze G, Kornhuber B, Lampert F, Niethammer D, Reiter A, Schellong G. Results and significance of six randomized trials in four consecutive ALL‐BFM studies. Haematology and Blood Transfusion, Acute Leu‐hemias II, T Buchner, G Schellong, W Hiddemann, J Ritter. Springer, Berlin Heidelberg 1990; 33: 439–449
- Mastrangelo R. The problem of “Staging” in Childhood Acute Lymphoblastic Leukemia: A Review. Med Pediatr Oncol 1986; 14(3)121–123
- Mastrangelo R, Poplack D, Bleyer A, Riccardi R, Sather H, D'Angio G. (The Writing Committee). Report and Recommendations of the Rome Workshop Concerning Poor‐Prognosis Acute Lymphoblastic Leukemia in Children: Biologic Bases for Staging, Stratification, and Treatment. Med Pediatr Oncol 1986; 14(3)191–194
- van der Does‐van den Berg A, Bartram C R., Basso G, Benoit C M., Biondi A, Debatin K M., Haas O A., Harbott J, Kamps W A., Roller U, Lampert F, Ludwig W D., Niemeyer C M., Wering E R. Minimal requirements for the Diagnosis, Classification, and Evaluation of the Treatment of Childhood Acute Lymphoblastic Leukemia (ALL) in the “BFM Family” Cooperative Group. Med Pediatr Oncol 1992; 20: 497–505
- Chessells J M. Treatment of Childhood Acute Lymphoblastic Leukaemia: Present Issues and Future Prospects. Blood Review 1992; 6: 193–203